Flaws in a tumor’s genetic mending kit drive treatment response to immunotherapy
Credit: Photo courtesy of Robbie B. Mailliard, PhD, University of Pittsburgh Graduate School of Public Health In an expanded, three-year clinical trial of 86 patients...








